Bristol-Myers Squibb | BMY - Operating Profit


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Bristol-Myers Squibb

Bristol-Myers Squibb reported $3.1B in Operating Profit for its fiscal quarter ending in March of 2023.


Operating Profit Change
AbbVie ABBV:US USD 2.77B 2.73B
Abbott ABT:US USD 1.51B 205M
ALKERMES ALKS:US USD -47494000 26.91M
Amgen AMGN:US USD 2.03B 196M
AstraZeneca AZN:LN USD 2.55B 1.46B
Biogen BIIB:US USD 507.7M 192.2M
Bristol-Myers Squibb BMY:US USD 3.1B 1.15B
Catalent CTLT:US USD 138M 78M
Coherus Biosciences CHRS:US USD -67745000 16.25M
Drreddys Laboratories RDY:US INR 12.38B 4.04B
Eli Lilly LLY:US USD 1.49B 342.4M
Endo International ENDP:US USD 3.46M 240.32M
Gilead Sciences GILD:US USD 1.7B 562M
GlaxoSmithKline GSK:LN GBP 2.08B 215M
Horizon Pharma HZNP:US USD 35.99M 137.94M
Intercept Pharmaceuticals ICPT:US USD -31632000 13.61M
J&J JNJ:US USD -737000000 4.94B
Merck & Co MRK:US USD 3.72B 286M
Novartis NOVN:VX USD 2.86B 907M
Perrigo PRGO:US USD 48.5M 17.5M
Pfizer PFE:US USD 6.79B 1.62B
Phibro Animal Health PAHC:US USD 18.55M 2.71M
Regeneron Pharmaceuticals REGN:US USD 946.7M 200.1M
Revance Therapeutics RVNC:US USD -58032000 86.38M
Roche Holding ROG:VX CHF 5.93B 5.62B
United Therapeutics UTHR:US USD 284.4M 108.8M
Zoetis ZTS:US USD 697M 105M